Carl I, Müller-Schauenburg W
Nuklearmed. Abt., Universität Tübingen.
Nuklearmedizin. 1990 Mar;29(2):59-70.
The arterial-to-portalvenous blood flow ratio (APV) has been determined routinely within liver bile studies carried out with 99mTc-hepatobida. Out of 1300 patients studied since 1978, 80 were analysed in detail concerning the fixed time parameters to separate the arterial and the portalvenous phase. The arterial phase was assumed to end 4 s after the first aortal peak, immediately followed by a portalvenous phase of 12 s duration. The "triangular area approach" of Biersack (1977) and George (1974) developed for pertechnetate and colloid, was directly applied to hepatobida. The fixed phase limits of hepatic circulation described above were compared to circulation parameters obtained from the beginning of the right ventricular recirculation and from the first decline of the spleen curve (for the end of the arterial phase), and from the second left ventricular peak (for the end of the portal phase). Our 4 s of aortal to end-arterial time agreed excellently with a corresponding control value of 4.1 s, as did the duration of the portal phase with 12 s compared to a control value of 12.1 s. An upper normal value of 45% APV was established, based upon sensitivity, specificity and a classification of hepatic curves. The "triangular area approach" appears at first to be inconsistent from a methodological point of view. We present a critical typology of assessing the APV. Basically we distinguish between strictly intravasal and all other types of tracer. The former are studied adequately by deconvolution and subsequent "real" area approaches, reflecting the full tracer passage through the liver. All not strictly intravasal tracers (pertechnetate, colloid, hepatobida) are subjected to a model assumption of a pure uptake without relevant tracer elimination during the first pass. We conclude that the Biersack-George method may be regarded as a heuristic correction of an amplitude approach within our typology, and that our fixed phase limits are justified by circulation analysis.
动脉与门静脉血流比(APV)已在使用99mTc-肝膦酸盐进行的肝脏胆汁研究中常规测定。自1978年以来研究的1300例患者中,对80例关于分离动脉期和门静脉期的固定时间参数进行了详细分析。动脉期假定在第一个主动脉峰值后4秒结束,紧接着是持续12秒的门静脉期。Biersack(1977年)和George(1974年)为高锝酸盐和胶体开发的“三角面积法”直接应用于肝膦酸盐。将上述肝脏循环的固定相界限与从右心室再循环开始以及脾脏曲线的首次下降(用于动脉期结束)和第二个左心室峰值(用于门静脉期结束)获得的循环参数进行比较。我们的主动脉到动脉末期时间为4秒,与相应的对照值4.1秒非常吻合,门静脉期持续时间为12秒,与对照值12.1秒相比也是如此。基于敏感性、特异性和肝脏曲线分类,确定了APV的正常上限值为45%。从方法论角度来看,“三角面积法”起初似乎不一致。我们提出了一种评估APV的批判性类型学。基本上,我们区分严格血管内和所有其他类型的示踪剂。前者通过反卷积和随后的“真实”面积法进行充分研究,反映示踪剂在肝脏中的完整通过情况。所有非严格血管内示踪剂(高锝酸盐、胶体、肝膦酸盐)在首次通过期间都采用纯摄取且无相关示踪剂消除的模型假设。我们得出结论,Biersack-George方法可被视为我们类型学中幅度法的启发式校正,并且我们的固定相界限通过循环分析是合理的。